Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA vs HEMO ORGANIC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAL PHARMA HEMO ORGANIC BAL PHARMA/
HEMO ORGANIC
 
P/E (TTM) x 40.8 -41.6 - View Chart
P/BV x 2.3 - - View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 BAL PHARMA   HEMO ORGANIC
EQUITY SHARE DATA
    BAL PHARMA
Mar-23
HEMO ORGANIC
Mar-23
BAL PHARMA/
HEMO ORGANIC
5-Yr Chart
Click to enlarge
High Rs13479 169.9%   
Low Rs637 956.3%   
Sales per share (Unadj.) Rs193.90 1,345,608.1%  
Earnings per share (Unadj.) Rs1.7-0.2 -1,053.1%  
Cash flow per share (Unadj.) Rs7.5-0.2 -4,724.0%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %1.00-  
Book value per share (Unadj.) Rs40.7-0.1 -27,661.9%  
Shares outstanding (eoy) m15.693.47 452.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.53,122.2 0.0%   
Avg P/E ratio x59.2-270.9 -21.8%  
P/CF ratio (eoy) x13.2-270.9 -4.9%  
Price / Book Value ratio x2.4-289.4 -0.8%  
Dividend payout %59.90-   
Avg Mkt Cap Rs m1,549148 1,044.7%   
No. of employees `000NANA-   
Total wages/salary Rs m5530-   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,0420 6,084,320.0%  
Other income Rs m90-   
Total revenues Rs m3,0520 6,103,140.0%   
Gross profit Rs m253-1 -45,909.1%  
Depreciation Rs m910-   
Interest Rs m1230-   
Profit before tax Rs m47-1 -8,634.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m210-   
Profit after tax Rs m26-1 -4,761.8%  
Gross profit margin %8.3-1,092.0 -0.8%  
Effective tax rate %44.80-   
Net profit margin %0.9-1,093.4 -0.1%  
BALANCE SHEET DATA
Current assets Rs m2,2822 112,948.5%   
Current liabilities Rs m2,0934 58,148.3%   
Net working cap to sales %6.2-3,172.0 -0.2%  
Current ratio x1.10.6 194.2%  
Inventory Days Days80-  
Debtors Days Days1,1284,319,629 0.0%  
Net fixed assets Rs m8290 4,142,500.0%   
Share capital Rs m15735 452.7%   
"Free" reserves Rs m481-35 -1,367.6%   
Net worth Rs m638-1 -125,076.5%   
Long term debt Rs m3050 87,208.6%   
Total assets Rs m3,1102 152,453.9%  
Interest coverage x1.40-  
Debt to equity ratio x0.5-0.7 -69.7%  
Sales to assets ratio x1.00 3,990.9%   
Return on assets %4.8-26.8 -17.9%  
Return on equity %4.1107.2 3.8%  
Return on capital %18.1341.3 5.3%  
Exports to sales %66.40-   
Imports to sales %22.40-   
Exports (fob) Rs m2,020NA-   
Imports (cif) Rs m683NA-   
Fx inflow Rs m2,0200-   
Fx outflow Rs m7160-   
Net fx Rs m1,3050-   
CASH FLOW
From Operations Rs m-181 -1,723.4%  
From Investments Rs m-222NA-  
From Financial Activity Rs m244NA-  
Net Cashflow Rs m41 349.5%  

Share Holding

Indian Promoters % 47.1 16.9 279.5%  
Foreign collaborators % 4.2 0.0 -  
Indian inst/Mut Fund % 0.1 0.0 -  
FIIs % 0.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.8 83.2 58.7%  
Shareholders   15,060 5,380 279.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAL PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BAL PHARMA vs DINESH ALLOR

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BAL PHARMA vs DINESH ALLOR Share Price Performance

Period BAL PHARMA DINESH ALLOR S&P BSE HEALTHCARE
1-Day -4.40% 2.82% 1.18%
1-Month -17.76% 18.47% -0.75%
1-Year 40.93% 47.19% 61.82%
3-Year CAGR 19.04% -11.27% 18.16%
5-Year CAGR 5.43% -8.84% 19.79%

* Compound Annual Growth Rate

Here are more details on the BAL PHARMA share price and the DINESH ALLOR share price.

Moving on to shareholding structures...

The promoters of BAL PHARMA hold a 51.2% stake in the company. In case of DINESH ALLOR the stake stands at 16.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BAL PHARMA and the shareholding pattern of DINESH ALLOR.

Finally, a word on dividends...

In the most recent financial year, BAL PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 59.9%.

DINESH ALLOR paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of BAL PHARMA, and the dividend history of DINESH ALLOR.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.